| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 8.40e-04 | 26 | 33 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 8.40e-04 | 26 | 33 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.12e-03 | 30 | 33 | 2 | GO:0016417 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 1.70e-03 | 37 | 33 | 2 | GO:0016409 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 3.61e-03 | 386 | 33 | 4 | GO:0042578 | |
| GeneOntologyBiologicalProcess | protein lipidation | 1.99e-05 | 101 | 33 | 4 | GO:0006497 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 2.40e-05 | 106 | 33 | 4 | GO:0042158 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 5.35e-05 | 259 | 33 | 5 | GO:0051651 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 5.72e-05 | 641 | 33 | 7 | GO:1901615 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 8.63e-05 | 147 | 33 | 4 | GO:0042157 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 1.51e-04 | 170 | 33 | 4 | GO:0046488 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 2.29e-04 | 801 | 33 | 7 | GO:0051046 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 2.34e-04 | 355 | 33 | 5 | GO:0046883 | |
| GeneOntologyBiologicalProcess | locomotion involved in locomotory behavior | 3.33e-04 | 17 | 33 | 2 | GO:0031987 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.84e-04 | 217 | 33 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | maintenance of location | 3.88e-04 | 396 | 33 | 5 | GO:0051235 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 4.54e-04 | 410 | 33 | 5 | GO:0006644 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 4.70e-04 | 229 | 33 | 4 | GO:0006643 | |
| GeneOntologyBiologicalProcess | hormone secretion | 5.07e-04 | 420 | 33 | 5 | GO:0046879 | |
| GeneOntologyBiologicalProcess | amide transport | 5.07e-04 | 420 | 33 | 5 | GO:0042886 | |
| GeneOntologyBiologicalProcess | signal release | 5.25e-04 | 653 | 33 | 6 | GO:0023061 | |
| GeneOntologyBiologicalProcess | hormone transport | 5.76e-04 | 432 | 33 | 5 | GO:0009914 | |
| GeneOntologyBiologicalProcess | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 6.70e-04 | 24 | 33 | 2 | GO:0018231 | |
| GeneOntologyBiologicalProcess | peptidyl-L-cysteine S-palmitoylation | 6.70e-04 | 24 | 33 | 2 | GO:0018230 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 6.70e-04 | 684 | 33 | 6 | GO:0010817 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine metabolic process | 7.88e-04 | 26 | 33 | 2 | GO:0042069 | |
| GeneOntologyBiologicalProcess | glycolipid metabolic process | 9.00e-04 | 119 | 33 | 3 | GO:0006664 | |
| GeneOntologyBiologicalProcess | liposaccharide metabolic process | 9.22e-04 | 120 | 33 | 3 | GO:1903509 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 9.58e-04 | 277 | 33 | 4 | GO:0090276 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.01e-03 | 740 | 33 | 6 | GO:1903530 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 1.02e-03 | 282 | 33 | 4 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 1.02e-03 | 282 | 33 | 4 | GO:0002791 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.20e-03 | 509 | 33 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 1.21e-03 | 132 | 33 | 3 | GO:0006661 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.24e-03 | 133 | 33 | 3 | GO:0007200 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.25e-03 | 1064 | 33 | 7 | GO:0032940 | |
| GeneOntologyBiologicalProcess | GPI anchor biosynthetic process | 1.27e-03 | 33 | 33 | 2 | GO:0006506 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 1.27e-03 | 33 | 33 | 2 | GO:0018345 | |
| GeneOntologyBiologicalProcess | GPI anchor metabolic process | 1.43e-03 | 35 | 33 | 2 | GO:0006505 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 1.50e-03 | 142 | 33 | 3 | GO:0018958 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.62e-03 | 146 | 33 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | 1.63e-03 | 320 | 33 | 4 | GO:0006650 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 1.64e-03 | 813 | 33 | 6 | GO:0008610 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.65e-03 | 147 | 33 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.72e-03 | 149 | 33 | 3 | GO:0051282 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.28e-04 | 1293 | 33 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.33e-04 | 1299 | 33 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.56e-04 | 1327 | 33 | 9 | GO:0042175 | |
| HumanPheno | Upslanted palpebral fissure | 1.25e-05 | 333 | 10 | 6 | HP:0000582 | |
| HumanPheno | Abnormal renal collecting system morphology | 2.15e-05 | 30 | 10 | 3 | HP:0004742 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 2.17e-05 | 366 | 10 | 6 | HP:0006265 | |
| HumanPheno | Brachydactyly (hand) | 5.47e-05 | 430 | 10 | 6 | HP:0100667 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanges of the hand | 6.27e-05 | 124 | 10 | 4 | HP:0009835 | |
| HumanPheno | Pulmonary hypoplasia | 9.01e-05 | 136 | 10 | 4 | HP:0002089 | |
| HumanPheno | Bicornuate uterus | 1.14e-04 | 52 | 10 | 3 | HP:0000813 | |
| HumanPheno | Aganglionic megacolon | 1.32e-04 | 150 | 10 | 4 | HP:0002251 | |
| HumanPheno | Megacolon | 1.32e-04 | 150 | 10 | 4 | HP:6000852 | |
| HumanPheno | Abnormal enteric ganglion morphology | 1.32e-04 | 150 | 10 | 4 | HP:0004362 | |
| HumanPheno | Abnormal enteric nervous system morphology | 1.36e-04 | 151 | 10 | 4 | HP:0025028 | |
| HumanPheno | Abnormal autonomic nervous system morphology | 1.36e-04 | 151 | 10 | 4 | HP:0012331 | |
| HumanPheno | Aplasia/Hypoplasia of the lungs | 1.70e-04 | 160 | 10 | 4 | HP:0006703 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 1.95e-04 | 538 | 10 | 6 | HP:0005927 | |
| HumanPheno | Short finger | 1.98e-04 | 325 | 10 | 5 | HP:0009381 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 2.35e-04 | 174 | 10 | 4 | HP:0009832 | |
| HumanPheno | Ureteral duplication | 2.44e-04 | 67 | 10 | 3 | HP:0000073 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 2.76e-04 | 572 | 10 | 6 | HP:0006496 | |
| HumanPheno | Small nail | 2.86e-04 | 183 | 10 | 4 | HP:0001792 | |
| HumanPheno | Cutaneous finger syndactyly | 3.03e-04 | 72 | 10 | 3 | HP:0010554 | |
| HumanPheno | Microretrognathia | 4.78e-04 | 84 | 10 | 3 | HP:0000308 | |
| HumanPheno | Finger syndactyly | 5.59e-04 | 218 | 10 | 4 | HP:0006101 | |
| HumanPheno | Micrognathia | 5.66e-04 | 89 | 10 | 3 | HP:0000210 | |
| HumanPheno | Abnormal hip bone morphology | 5.77e-04 | 653 | 10 | 6 | HP:0003272 | |
| HumanPheno | 2-3 toe cutaneous syndactyly | 6.47e-04 | 20 | 10 | 2 | HP:0005709 | |
| HumanPheno | Brachydactyly | 6.65e-04 | 670 | 10 | 6 | HP:0001156 | |
| HumanPheno | Short digit | 6.76e-04 | 672 | 10 | 6 | HP:0011927 | |
| HumanPheno | Multicystic kidney dysplasia | 7.51e-04 | 98 | 10 | 3 | HP:0000003 | |
| HumanPheno | Congenital diaphragmatic hernia | 7.97e-04 | 100 | 10 | 3 | HP:0000776 | |
| HumanPheno | Craniofacial cleft | 8.07e-04 | 694 | 10 | 6 | HP:5201015 | |
| HumanPheno | Orofacial cleft | 8.07e-04 | 694 | 10 | 6 | HP:0000202 | |
| HumanPheno | Abnormal lung development | 8.58e-04 | 244 | 10 | 4 | HP:4000059 | |
| HumanPheno | Toe syndactyly | 8.58e-04 | 244 | 10 | 4 | HP:0001770 | |
| HumanPheno | Cutaneous syndactyly | 8.69e-04 | 103 | 10 | 3 | HP:0012725 | |
| HumanPheno | Duplicated collecting system | 9.36e-04 | 24 | 10 | 2 | HP:0000081 | |
| HumanPheno | Bifid tongue | 1.02e-03 | 25 | 10 | 2 | HP:0010297 | |
| HumanPheno | Aplasia/Hypoplasia of the nails | 1.06e-03 | 258 | 10 | 4 | HP:0008386 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 1.06e-03 | 730 | 10 | 6 | HP:0002644 | |
| HumanPheno | Abnormal finger phalanx morphology | 1.13e-03 | 738 | 10 | 6 | HP:0005918 | |
| HumanPheno | Slanting of the palpebral fissure | 1.14e-03 | 739 | 10 | 6 | HP:0200006 | |
| HumanPheno | Hip dislocation | 1.14e-03 | 263 | 10 | 4 | HP:0002827 | |
| HumanPheno | Hydronephrosis | 1.16e-03 | 264 | 10 | 4 | HP:0000126 | |
| HumanPheno | Aplasia involving bones of the extremities | 1.32e-03 | 759 | 10 | 6 | HP:0009825 | |
| HumanPheno | Short distal phalanx of finger | 1.32e-03 | 119 | 10 | 3 | HP:0009882 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 1.34e-03 | 761 | 10 | 6 | HP:0045060 | |
| HumanPheno | Abnormal hip joint morphology | 1.35e-03 | 490 | 10 | 5 | HP:0001384 | |
| HumanPheno | Fetal ultrasound soft marker | 1.46e-03 | 123 | 10 | 3 | HP:0011425 | |
| HumanPheno | Abnormal synovial membrane morphology | 1.52e-03 | 503 | 10 | 5 | HP:0005262 | |
| HumanPheno | Dilatation of the renal pelvis | 1.64e-03 | 290 | 10 | 4 | HP:0010946 | |
| HumanPheno | Abnormal nail morphology | 1.71e-03 | 516 | 10 | 5 | HP:0001597 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 1.82e-03 | 298 | 10 | 4 | HP:0006494 | |
| HumanPheno | Abnormal renal pelvis morphology | 1.87e-03 | 300 | 10 | 4 | HP:0010944 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 1.91e-03 | 813 | 10 | 6 | HP:0009815 | |
| HumanPheno | Abnormal fetal morphology | 2.11e-03 | 310 | 10 | 4 | HP:0034058 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 2.12e-03 | 140 | 10 | 3 | HP:0001991 | |
| HumanPheno | Regional abnormality of skin | 2.12e-03 | 541 | 10 | 5 | HP:0011356 | |
| HumanPheno | Abnormality of the diaphragm | 2.16e-03 | 141 | 10 | 3 | HP:0000775 | |
| HumanPheno | Lower extremity joint dislocation | 2.32e-03 | 318 | 10 | 4 | HP:0030311 | |
| HumanPheno | Micrognathia | 2.32e-03 | 843 | 10 | 6 | HP:0000347 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 2.34e-03 | 319 | 10 | 4 | HP:0009767 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | 2.35e-03 | 845 | 10 | 6 | HP:0009118 | |
| HumanPheno | Epiphyseal stippling | 2.60e-03 | 40 | 10 | 2 | HP:0010655 | |
| HumanPheno | Calcific stippling | 2.73e-03 | 41 | 10 | 2 | HP:0002832 | |
| Domain | zf-DHHC | 7.04e-04 | 23 | 32 | 2 | PF01529 | |
| Domain | DHHC | 8.32e-04 | 25 | 32 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 8.32e-04 | 25 | 32 | 2 | IPR001594 | |
| Domain | GPCR_Rhodpsn_7TM | 5.28e-03 | 670 | 32 | 5 | IPR017452 | |
| Domain | 7tm_1 | 5.51e-03 | 677 | 32 | 5 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.79e-03 | 685 | 32 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.01e-03 | 691 | 32 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.04e-03 | 692 | 32 | 5 | IPR000276 | |
| Domain | C2 | 2.11e-02 | 131 | 32 | 2 | PF00168 | |
| Domain | C2 | 2.29e-02 | 137 | 32 | 2 | SM00239 | |
| Domain | C2 | 2.45e-02 | 142 | 32 | 2 | PS50004 | |
| Domain | - | 2.65e-02 | 148 | 32 | 2 | 2.60.40.150 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS | 5.80e-05 | 7 | 24 | 2 | M39848 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS | 2.14e-04 | 13 | 24 | 2 | M47945 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 2.39e-04 | 72 | 24 | 3 | M46457 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.54e-04 | 186 | 24 | 4 | MM15994 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS | 2.88e-04 | 15 | 24 | 2 | MM15921 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M39608 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 3.72e-04 | 17 | 24 | 2 | M5872 | |
| Pathway | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | 3.72e-04 | 17 | 24 | 2 | MM14621 | |
| Pathway | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | 4.18e-04 | 18 | 24 | 2 | M1093 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 4.67e-04 | 19 | 24 | 2 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.72e-04 | 21 | 24 | 2 | M47542 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS | 7.49e-04 | 24 | 24 | 2 | M47625 | |
| Pathway | KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS | 8.14e-04 | 25 | 24 | 2 | M13265 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 8.52e-04 | 111 | 24 | 3 | M48065 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 9.50e-04 | 27 | 24 | 2 | M16227 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 9.50e-04 | 27 | 24 | 2 | MM14735 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE | 1.02e-03 | 28 | 24 | 2 | M42536 | |
| Pathway | PID_BARD1_PATHWAY | 1.10e-03 | 29 | 24 | 2 | M258 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.23e-03 | 126 | 24 | 3 | MM15553 | |
| Pathway | WP_ENTEROCYTE_CHOLESTEROL_METABOLISM | 1.69e-03 | 36 | 24 | 2 | M48067 | |
| Pubmed | Genetic disorders of cholesterol biosynthesis in mice and humans. | 5.23e-06 | 4 | 33 | 2 | 11592808 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 6.26e-05 | 742 | 33 | 6 | 26871637 | |
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 15603741 | ||
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 33634103 | ||
| Pubmed | Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. | 1.18e-04 | 17 | 33 | 2 | 11102867 | |
| Pubmed | 1.46e-04 | 283 | 33 | 4 | 21903422 | ||
| Pubmed | 1.57e-04 | 878 | 33 | 6 | 37223481 | ||
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 33304758 | ||
| Pubmed | A compendium of expression patterns of cholesterol biosynthetic enzymes in the mouse embryo. | 5.69e-04 | 37 | 33 | 2 | 26108225 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 6.01e-04 | 38 | 33 | 2 | 12482669 | |
| Pubmed | 7.88e-04 | 191 | 33 | 3 | 31177093 | ||
| Interaction | CERS5 interactions | 2.06e-05 | 36 | 30 | 3 | int:CERS5 | |
| Interaction | MFSD14A interactions | 3.20e-05 | 6 | 30 | 2 | int:MFSD14A | |
| Interaction | MFSD6 interactions | 3.29e-05 | 42 | 30 | 3 | int:MFSD6 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 3.75e-04 | 195 | 33 | 3 | chr10q23 | |
| Cytoband | 15q23 | 4.65e-04 | 44 | 33 | 2 | 15q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q23 | 1.11e-03 | 68 | 33 | 2 | chr15q23 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.46e-04 | 78 | 24 | 3 | 262 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 3.49e-04 | 21 | 24 | 2 | 680 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 4.58e-04 | 24 | 24 | 2 | 76 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-06 | 173 | 33 | 4 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-06 | 173 | 33 | 4 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.47e-06 | 176 | 33 | 4 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 33 | 4 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 33 | 4 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 33 | 4 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 1.27e-05 | 195 | 33 | 4 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 1.32e-05 | 197 | 33 | 4 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.40e-05 | 200 | 33 | 4 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| Computational | Genes in the cancer module 432. | 1.89e-04 | 15 | 15 | 2 | MODULE_432 | |
| Computational | Genes in the cancer module 340. | 5.79e-04 | 26 | 15 | 2 | MODULE_340 | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; HL60; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 2395_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 8.06e-06 | 199 | 32 | 5 | 3082_DN | |
| Drug | SbH3 | 4.00e-05 | 7 | 32 | 2 | CID000009359 | |
| Drug | 26 d | 1.04e-04 | 11 | 32 | 2 | CID000008861 | |
| Drug | dppz | 1.04e-04 | 11 | 32 | 2 | CID003081616 | |
| Drug | MDL 72832 | 1.48e-04 | 13 | 32 | 2 | CID000182585 | |
| Drug | AC1L99QI | 1.48e-04 | 13 | 32 | 2 | CID000440671 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 3624_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 5986_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A | 1.52e-04 | 194 | 32 | 4 | 1783_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; HL60; HG-U133A | 1.52e-04 | 194 | 32 | 4 | 1424_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 2317_UP | |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 7460_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1854_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; HL60; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1996_DN | |
| Drug | LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 1157_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4142_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 5513_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HG-U133A | 1.68e-04 | 199 | 32 | 4 | 1918_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 4701_DN | |
| Drug | diazepine | 1.72e-04 | 14 | 32 | 2 | CID000166734 | |
| Drug | Gd 7 | 2.27e-04 | 16 | 32 | 2 | CID000092808 | |
| Drug | 2,5-dimethoxy-4-bromoamphetamine | 2.57e-04 | 17 | 32 | 2 | CID000062064 | |
| Drug | AC1L9IU6 | 2.89e-04 | 18 | 32 | 2 | CID000445952 | |
| Drug | 4,4'-dimethyl-2,2'-bipyridine | 3.95e-04 | 21 | 32 | 2 | CID000014338 | |
| Drug | N-benzoyl-N'-beta-D-glucopyranosyl urea | 4.75e-04 | 23 | 32 | 2 | CID000446600 | |
| Drug | adinazolam | 4.75e-04 | 23 | 32 | 2 | CID000037632 | |
| Drug | tyrphostin B46 | 4.75e-04 | 23 | 32 | 2 | CID000002058 | |
| Drug | alpidem | 5.18e-04 | 24 | 32 | 2 | CID000054897 | |
| Drug | difenoconazole | 5.63e-04 | 25 | 32 | 2 | ctd:C115058 | |
| Drug | AC1L1OP3 | 6.09e-04 | 26 | 32 | 2 | CID000032933 | |
| Drug | 8-dehydrocholesterol | 7.07e-04 | 28 | 32 | 2 | CID000129846 | |
| Drug | zymosterol | 1.04e-03 | 34 | 32 | 2 | CID000092746 | |
| Drug | phendioxan | 1.11e-03 | 35 | 32 | 2 | CID000185453 | |
| Drug | pregnanetriol | 1.17e-03 | 36 | 32 | 2 | CID000101967 | |
| Drug | atomoxetine | 1.17e-03 | 36 | 32 | 2 | CID000054840 | |
| Drug | FG 7142 | 1.17e-03 | 36 | 32 | 2 | CID000004375 | |
| Drug | CT 6 | 1.24e-03 | 37 | 32 | 2 | CID005327130 | |
| Drug | DMCM | 1.30e-03 | 38 | 32 | 2 | CID000104999 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.46e-03 | 52 | 32 | 2 | C1168401 | |
| Disease | Weight Gain | 5.49e-03 | 102 | 32 | 2 | C0043094 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLAILYDYVWPLPRY | 111 | P28335 | |
| CVWLPYLYTLQGLYL | 311 | Q9UBM7 | |
| LYFIPLRYIILIWGI | 811 | Q6DN12 | |
| PVDPIEYLALWIYKY | 26 | Q8WWB3 | |
| YTPLLSYLRLYDNPW | 151 | Q8N6Y2 | |
| TEDGYILGLYRIPYW | 21 | Q5W064 | |
| IGYLYTYWAPLGFVL | 176 | O43861 | |
| LLFLLLWGPYVVASY | 291 | Q9NS67 | |
| LYLWLFLLGLPFTLY | 36 | Q96RV3 | |
| YLLWEALVYSDYLIL | 271 | Q8TDT2 | |
| LLVYDLYLSPKLWAL | 186 | Q9BRS8 | |
| LEPNGIILYYTVYVW | 921 | Q9UMZ3 | |
| LLGWGPYAILYLYAV | 221 | P47804 | |
| SYTFLYWLPLYIANV | 311 | Q8TED4 | |
| AEPPTALLWLLAFYY | 416 | Q00597 | |
| YLKSALNPLIYYWRI | 361 | Q9BZJ6 | |
| LWYRAPEILLGCKYY | 166 | P24941 | |
| YLWVLKILYPSTLFL | 141 | P16298 | |
| LPLAVTLYVSWLLYL | 96 | Q6J4K2 | |
| WSYYIGYLRLILPEL | 161 | Q86WV6 | |
| IILYTYPRGQIIYTW | 426 | Q9Y6U3 | |
| LLTYGRWQYPLIYGL | 221 | Q9BX95 | |
| VLSVLLWLGPFFYYL | 361 | Q8NG04 | |
| PYWVAYYLALLLSLL | 296 | Q15738 | |
| VLPVWLNYYGKLLPY | 66 | Q6RSH7 | |
| WIIFILGYLTGYYVH | 61 | B2RUZ4 | |
| LLLVAPSGLYYWYLV | 211 | Q9NWW5 | |
| WILFPLLGCYAVYSL | 481 | O96005 | |
| PVTRYILGYFLTYWL | 466 | Q9NUD9 | |
| WTYYVYGLLPLPIWY | 506 | O95427 | |
| VILRVDPKGYYLYWT | 36 | Q00722 | |
| VLTSLPVLALWYYYL | 116 | Q8IYP9 | |
| ITLLLGWSYYAYAIQ | 26 | Q9UIJ5 | |
| WYQVSPLAARLLYPY | 126 | P30536 |